Proposed Data Collections Submitted for Public Comment and Recommendations, 31554-31555 [2013-12406]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
31554
Federal Register / Vol. 78, No. 101 / Friday, May 24, 2013 / Notices
who wish to attend the meeting and/or
participate in the public comment
session should register at https://
www.hhs.gov/nvpo/nvac, email
nvpo@hhs.gov, or call 202–690–5566
and provide name, organization, and
email address.
DATES: The meeting will be held on June
11–12, 2013. The meeting times and
agenda will be posted on the NVAC
Web site at https://www.hhs.gov/nvpo/
nvac as soon they become available.
ADDRESSES: U.S. Department of Health
and Human Services, 200 Independence
Avenue SW., Room 800, Washington,
DC 20201.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services,, 200 Independence Avenue
SW., Room 715–H, Washington, DC
20201. Phone: (202) 690–5566; fax: (202)
690–4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
The topics to be discussed at the
NVAC meeting will include adult
immunizations, pertussis, influenza
A(H7N9), immunizations and the
Affordable Care Act, and updates from
the NVAC working groups on global
immunization and maternal
immunization. The meeting agenda will
be posted on the NVAC Web site: https://
www.hhs.gov/nvpo/nvac prior to the
meeting.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
National Vaccine Program Office at the
address/phone listed above at least one
week prior to the meeting. Members of
the public will have the opportunity to
provide comments at the NVAC meeting
during the public comment periods on
the agenda. Individuals who would like
to submit written statements should
email or fax their comments to the
VerDate Mar<15>2010
21:14 May 23, 2013
Jkt 229001
National Vaccine Program Office at least
five business days prior to the meeting.
Dated: May 16, 2013.
Bruce Gellin,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2013–12419 Filed 5–23–13; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-13–0612]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) Reporting
System (OMB #0920–0612, exp. 1/31/
2014)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cardiovascular disease (CVD), which
includes heart disease, myocardial
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
infarction, and stroke, is the leading
cause of death for women in the United
States, and is largely preventable. The
WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women
Across the Nation), administered by the
Centers for Disease Control and
Prevention (CDC), was established to
examine ways to improve the delivery
of services for women who have limited
access to health care and elevated risk
factors for CVD. The program focuses on
reducing CVD risk factors and provides
screening services for select risk factors
such as elevated blood cholesterol,
hypertension and abnormal blood
glucose levels. The program also
provides women with referrals to
lifestyle programs and medical care. The
WISEWOMAN program currently
provides services to approximately
45,000 women who are jointly enrolled
in the National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP), also administered by CDC.
The current cooperative agreements for
WISEWOMAN awardees end June 30,
2013 and final submissions to CDC are
due no later than October 31, 2013. CDC
obtained OMB approval to collect
information from these awardees
through the ‘‘WISEWOMAN Reporting
System,’’ OMB No. 0920–0612, exp. 1/
31/2014. The information submitted to
CDC includes semi-annual progress
reports and minimum data elements
(MDE) that are also submitted twice per
year.
The WISEWOMAN program will
continue under a new set of four-year
cooperative agreements that begin July
1, 2013 and end June 30, 2017. The new
funding period will reflect an increased
emphasis on efficient oversight of
program awardees and documenting
program outcomes. As a result, the
WISEWOMAN information collection
will be revised to support updated
program goals. Changes to be
implemented in the new cooperative
agreement funding cycle include a
reduction in the frequency of progress
report submission—from twice per year
to once per year—and changes to the
content of the MDE submissions. The
first reports based on the revised
reporting requirements will be
submitted to CDC in April 2014.
The hardcopy progress report
provides a narrative summary of each
awardee’s objectives and the activities
undertaken to meet program goals,
including public education and
outreach. The estimated burden per
response is 8 hours. In the new
cooperative agreement cycle, the
frequency of response will decrease
from twice per year to once per year,
resulting in a net decrease in respondent
E:\FR\FM\24MYN1.SGM
24MYN1
31555
Federal Register / Vol. 78, No. 101 / Friday, May 24, 2013 / Notices
burden for progress reporting. In the
future, CDC may transition from a
hardcopy report to MIS-based progress
reporting.
The MDE information submitted to
CDC includes baseline and follow-up
data (12 months post enrollment) for all
women served through the
WISEWOMAN program. The MDE
describe risk factors for the women
served in each program and the number
and type of lifestyle program sessions
they attend. The information allows
CDC to assess the effectiveness of the
WISEWOMAN program in reducing the
burden of cardiovascular disease risk
factors among women who utilize
program services. MDE information may
also be utilized in assessments of
WISEWOMAN program impact and
cost-effectiveness. MDE information has
previously been submitted to CDC in
overall program evaluation is designed
to demonstrate how WISEWOMAN can
obtain more complete health data on
vulnerable populations, promote public
education about disease incidence,
cardiovascular disease risk-factors,
health promotion, to improve the
availability of screening and diagnostic
services for under-served women,
ensure the quality of services provided
to under-served women, and develop
strategies for improved interventions.
The estimated number of
WISEWOMAN awardees is 21 but may
be adjusted when new cooperative
agreements are issued. Participation in
this information collection is required
as a condition of cooperative agreement
funding. There are no costs to
respondents other than their time.
two electronic transmissions: the
burden for Screening and Assessment
MDE was estimated at 16 hours per
response and the burden for Lifestyle
Intervention MDE was estimated at 8
hours per response. Under the new
WISEWOMAN cooperative agreements,
the MDE will be submitted as a single
electronic file with a combined
estimated burden per response of 24
hours. The total number of MDE
variables will increase from 66 to 87.
The number of variables relating to
Lifestyle Interventions will decrease and
the number of variables relating to
Screening and Assessment will increase.
CDC will continue to use the
information collected from
WISEWOMAN awardees to support
continuous program monitoring and
improvement activities, evaluation, and
assessment of program outcomes. The
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
WISEWOMAN Grantees
Average
burden per
response
(in hrs)
Number of
responses per
respondent
Number of
respondents
Form name
Total burden
(in hrs)
21
2
24
1,008
........................................
Screening and Assessment and Lifestyle Program MDEs.
Annual Progress Report .................................
21
1
8
168
Total ............................
.........................................................................
........................
........................
........................
1,176
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–12406 Filed 5–23–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–64, CMS–10295
and CMS–10401]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
21:14 May 23, 2013
Jkt 229001
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection;
Title of Information Collection:
Quarterly Medicaid Statement of
Expenditures for the Medical Assistance
Program; Use: Form CMS–64 has been
used since January 1980 by Medicaid
state agencies to report their actual
program benefit costs and
administrative expenses. CMS uses this
information to compute the federal
financial participation for the state’s
Medicaid program costs. Certain
schedules of the CMS–64 form are used
by states to report budget, expenditure
and related statistical information
required for implementation of the
Medicaid portion of the State Children’s
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Health Insurance Programs, Title XXI of
the Social Security Act, established by
the Balanced Budget Act of 1997. Form
Number: CMS–64 (OCN: 0938–0067);
Frequency: Quarterly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 56; Total
Annual Responses: 224; Total Annual
Hours: 16,464. (For policy questions
regarding this collection contact
Abraham John at 410–786–4518. For all
other issues call 410–786–1326.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Reporting
Requirements for States Under
Transitional Medical Assistance (TMA)
Provisions; Use: The HHS Secretary is
required to submit annual reports to
Congress with information collected
from states in accordance with section
5004(d) of the American Recovery and
Reinvestment Act of 2009. Medicaid
agencies in 50 states complete the
reports while we review the information
to determine if each state has met all of
the reporting requirements specified
under section 5004(d). We are revising
this package to remove the requirement
to report the Medicaid Federal Medical
Assistance Percentage since it no longer
needs to be collected from states. Form
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 78, Number 101 (Friday, May 24, 2013)]
[Notices]
[Pages 31554-31555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-13-0612]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Well-Integrated Screening and Evaluation for Women Across the
Nation (WISEWOMAN) Reporting System (OMB 0920-0612, exp. 1/31/
2014)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Cardiovascular disease (CVD), which includes heart disease,
myocardial infarction, and stroke, is the leading cause of death for
women in the United States, and is largely preventable. The WISEWOMAN
program (Well-Integrated Screening and Evaluation for Women Across the
Nation), administered by the Centers for Disease Control and Prevention
(CDC), was established to examine ways to improve the delivery of
services for women who have limited access to health care and elevated
risk factors for CVD. The program focuses on reducing CVD risk factors
and provides screening services for select risk factors such as
elevated blood cholesterol, hypertension and abnormal blood glucose
levels. The program also provides women with referrals to lifestyle
programs and medical care. The WISEWOMAN program currently provides
services to approximately 45,000 women who are jointly enrolled in the
National Breast and Cervical Cancer Early Detection Program (NBCCEDP),
also administered by CDC. The current cooperative agreements for
WISEWOMAN awardees end June 30, 2013 and final submissions to CDC are
due no later than October 31, 2013. CDC obtained OMB approval to
collect information from these awardees through the ``WISEWOMAN
Reporting System,'' OMB No. 0920-0612, exp. 1/31/2014. The information
submitted to CDC includes semi-annual progress reports and minimum data
elements (MDE) that are also submitted twice per year.
The WISEWOMAN program will continue under a new set of four-year
cooperative agreements that begin July 1, 2013 and end June 30, 2017.
The new funding period will reflect an increased emphasis on efficient
oversight of program awardees and documenting program outcomes. As a
result, the WISEWOMAN information collection will be revised to support
updated program goals. Changes to be implemented in the new cooperative
agreement funding cycle include a reduction in the frequency of
progress report submission--from twice per year to once per year--and
changes to the content of the MDE submissions. The first reports based
on the revised reporting requirements will be submitted to CDC in April
2014.
The hardcopy progress report provides a narrative summary of each
awardee's objectives and the activities undertaken to meet program
goals, including public education and outreach. The estimated burden
per response is 8 hours. In the new cooperative agreement cycle, the
frequency of response will decrease from twice per year to once per
year, resulting in a net decrease in respondent
[[Page 31555]]
burden for progress reporting. In the future, CDC may transition from a
hardcopy report to MIS-based progress reporting.
The MDE information submitted to CDC includes baseline and follow-
up data (12 months post enrollment) for all women served through the
WISEWOMAN program. The MDE describe risk factors for the women served
in each program and the number and type of lifestyle program sessions
they attend. The information allows CDC to assess the effectiveness of
the WISEWOMAN program in reducing the burden of cardiovascular disease
risk factors among women who utilize program services. MDE information
may also be utilized in assessments of WISEWOMAN program impact and
cost-effectiveness. MDE information has previously been submitted to
CDC in two electronic transmissions: the burden for Screening and
Assessment MDE was estimated at 16 hours per response and the burden
for Lifestyle Intervention MDE was estimated at 8 hours per response.
Under the new WISEWOMAN cooperative agreements, the MDE will be
submitted as a single electronic file with a combined estimated burden
per response of 24 hours. The total number of MDE variables will
increase from 66 to 87. The number of variables relating to Lifestyle
Interventions will decrease and the number of variables relating to
Screening and Assessment will increase.
CDC will continue to use the information collected from WISEWOMAN
awardees to support continuous program monitoring and improvement
activities, evaluation, and assessment of program outcomes. The overall
program evaluation is designed to demonstrate how WISEWOMAN can obtain
more complete health data on vulnerable populations, promote public
education about disease incidence, cardiovascular disease risk-factors,
health promotion, to improve the availability of screening and
diagnostic services for under-served women, ensure the quality of
services provided to under-served women, and develop strategies for
improved interventions.
The estimated number of WISEWOMAN awardees is 21 but may be
adjusted when new cooperative agreements are issued. Participation in
this information collection is required as a condition of cooperative
agreement funding. There are no costs to respondents other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hrs)
respondent hrs)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Grantees Screening and 21 2 24 1,008
Assessment and
Lifestyle
Program MDEs.
Annual Progress 21 1 8 168
Report.
-------------------------------
Total..................... ................ .............. .............. .............. 1,176
----------------------------------------------------------------------------------------------------------------
Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013-12406 Filed 5-23-13; 8:45 am]
BILLING CODE 4163-18-P
